Lindbrook Capital, LLC - CEREVEL THERAPEUTICS HLDNG I ownership

CEREVEL THERAPEUTICS HLDNG I's ticker is CERE and the CUSIP is 15678U128. A total of 109 filers reported holding CEREVEL THERAPEUTICS HLDNG I in Q4 2021. The put-call ratio across all filers is 0.33 and the average weighting 0.3%.

Quarter-by-quarter ownership
Lindbrook Capital, LLC ownership history of CEREVEL THERAPEUTICS HLDNG I
ValueSharesWeighting
Q3 2023$1,965
-17.6%
90
+20.0%
0.00%
Q2 2023$2,384
-40.4%
75
-42.3%
0.00%
-100.0%
Q4 2021$4,000
+300.0%
130
+160.0%
0.00%
Q3 2021$1,000500.00%
Other shareholders
CEREVEL THERAPEUTICS HLDNG I shareholders Q4 2021
NameSharesValueWeighting ↓
Anchor Investment Management, LLC 100$4,2400.00%
View complete list of CEREVEL THERAPEUTICS HLDNG I shareholders